Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 43,008 | N/A |
| Marketable Securities | 6,958 | N/A |
| Receivables | 925 | N/A |
| TOTAL | $50,891 | $N/A |
| Non-Current Assets | ||
| PPE Net | 248 | N/A |
| Investments And Advances | 104 | 0 |
| Other Non-Current Assets | 34 | 0 |
| TOTAL | $386 | $N/A |
| Total Assets | $51,277 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 505 | N/A |
| Accounts payable and accrued liabilities | 626 | 0 |
| Other current liabilities | 968 | N/A |
| TOTAL | $2,134 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 51 | N/A |
| Deferred Revenues | 35 | N/A |
| Other Non-Current Liabilities | 330 | 0 |
| TOTAL | $381 | $N/A |
| Total Liabilities | $2,515 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 954 | N/A |
| Retained earnings | -29,713 | N/A |
| Other shareholders' equity | -79 | 0 |
| TOTAL | $48,762 | $N/A |
| Total Liabilities And Equity | $51,277 | $0 |